Remicade® infliximab

Find a Specialist | Contact Us | For Healthcare Professionals

Psoriasis
Rheumatoid Arthritis
Psoriatic Arthritis
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Ankylosing Spondylitis
REMICADE for AS
Important Safety Information

 

REMICADE for AS

Resource Center
Medical Specialist LocatorMedical Specialist Locator
Remicade News and UpdatesREMICADE News
and Updates

REMICADE treats an underlying cause of ankylosing spondylitis (AS).

AS is not just a disease of the spine — it is a complex disease that affects the whole body. A few years ago, AS patients had only NSAIDs (nonsteroidal anti-inflammatory drugs) and painkillers to manage ankylosing spondylitis symptoms, but they were only minimally effective. Now that you have been diagnosed with AS, you have a great opportunity to improve many of your symptoms by using REMICADE.

Here are some reasons that you should make your move to REMICADE:

  • REMICADE works with your immune system to block TNF-alpha, a protein in your body that triggers the inflammation leading to symptoms of AS.
  • REMICADE is an advanced medicine that can reduce symptoms of AS in as soon as two weeks after you begin treatment. Individual results may vary.
  • REMICADE has been proven to relieve many ankylosing spondylitis symptoms, such as spinal pain (pain in the back, neck, and hip), fatigue, and morning stiffness. Individual results may vary.
  • By improving the many symptoms of AS, REMICADE can quickly and effectively help you enjoy everyday activities by permitting you to accomplish such activities with less pain. Individual results may vary.

For further information about studies involving REMICADE and AS, please visit the following resource:

Also see:

Strong enough to change the course of AS therapy.
This brochure provides information about AS and how REMICADE works to treat AS. En Español
(Requires Adobe® Acrobat® Reader. Click here to download)


IMPORTANT SAFETY INFORMATION | Privacy Policy | Legal Notice | Site Map | About Centocor Ortho Biotech Inc.

© Centocor Ortho Biotech Inc. 1999-2009
This site is published by Centocor Ortho Biotech Inc. which is solely responsible for its contents.
It is intended for residents from the United States.
Last Updated: January 19, 2009